The Immunosuppression Summit 2016 will bring together international scientists, clinicians and industry professionals in order to discuss the many aspects of immunosuppression, immunotherapy and vaccination. With topics ranging from tumour immunosuppression and HIV, to antibodies and biomarkers, this event promises to appeal to all scientists working within this ever-growing field.
The problems of immunosuppression will be discussed, and research into overcoming them will be debated in an informal, academic setting.
A late registration fee applies after January 20th 2016.
Who should attend?
This summit will interest those working in drug design and discovery, physicians and clinicians, research scientists and academics, and those who work within the industry.
This event has an open abstract session.
Abstracts can be submitted on any subject related to Immunosuppression and Immunotherapy.
The Deadline for abstract submissions for oral presentation is December 10th 2015.
Abstracts for poster presentation only can be submitted up to two weeks before the event.
You can download the instructions for authors at:
www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
This event has CPD accreditation
The problems of immunosuppression will be discussed, and research into overcoming them will be debated in an informal, academic setting.
A late registration fee applies after January 20th 2016.
Who should attend?
This summit will interest those working in drug design and discovery, physicians and clinicians, research scientists and academics, and those who work within the industry.
This event has an open abstract session.
Abstracts can be submitted on any subject related to Immunosuppression and Immunotherapy.
The Deadline for abstract submissions for oral presentation is December 10th 2015.
Abstracts for poster presentation only can be submitted up to two weeks before the event.
You can download the instructions for authors at:
www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
This event has CPD accreditation
